Literature DB >> 7789613

Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes.

S M Viselli1, N J Olsen, K Shults, G Steizer, W J Kovacs.   

Abstract

A variety of evidence suggests that the cells of the immune system are targets for the actions of gonadal steroids. Experiments in both normal animals and in autoimmune disease models have established that androgens exert immunomodulatory effects at the level of the thymus. We have attempted to define precisely the potential target cells for androgen action in the thymus using recently developed antibodies to the androgen receptor. We report here that these antibodies reveal AR expression in all classes of thymocytes defined by surface markers CD4 and CD8. The highest levels of AR expression were observed in the CD4-CD8+ and CD4-CD8- subsets that include the most immature cells. These experiments establish that thymocytes are potential targets for direct actions of androgens. The data further suggest AR expression in thymocytes may be developmentally regulated in these cells, and that androgen effects early in the process of thymocyte selection may contribute to the sexual dimorphism of immune responsiveness.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789613     DOI: 10.1016/0303-7207(95)03479-q

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

Review 1.  Effects of androgens on T and B lymphocyte development.

Authors:  N J Olsen; W J Kovacs
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 3.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 4.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

5.  Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy.

Authors:  Kuo-Pao Lai; Jiann-Jyh Lai; Philip Chang; Saleh Altuwaijri; Jong-Wei Hsu; Kuang-Hsiang Chuang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2012-12-18

6.  Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.

Authors:  Heather S L Jim; Jong Y Park; Jennifer Permuth-Wey; Maria A Rincon; Kristin M Phillips; Brent J Small; Paul B Jacobsen
Journal:  Brain Behav Immun       Date:  2012-03-28       Impact factor: 7.217

7.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation.

Authors:  Ryan M Kelly; Steven L Highfill; Angela Panoskaltsis-Mortari; Patricia A Taylor; Richard L Boyd; Georg A Holländer; Bruce R Blazar
Journal:  Blood       Date:  2008-03-11       Impact factor: 22.113

Review 9.  Immunotherapy for prostate cancer: recent developments and future challenges.

Authors:  Michael T Schweizer; Charles G Drake
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 10.  Thymic involution and immune reconstitution.

Authors:  Heather E Lynch; Gabrielle L Goldberg; Ann Chidgey; Marcel R M Van den Brink; Richard Boyd; Gregory D Sempowski
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.